Redefining
Infectious Disease
Diagnostics with
Harnessing the Power of Next Generation Sequencing (NGS)
Next Generation Sequencing is revolutionizing the speed and accuracy with which pathogens in clinical samples are detected. HaystackAnalytics with its innovative clinical genomic solutions, infexn®-NGS powered by Universal ID™ CE-IVD (DNA enrichment kit) and the proprietary bioinformatics platform (Ω ID™) is now bringing a transformative precision to infection management.
Why infexn®–NGS?
One Universal Diagnostic Framework for Any Suspected Infection
Infections rarely follow predictable rules. infexn®–NGS replaces targeted guesswork with a hypothesis-free metagenomic platform capable of evaluating any infectious disease presentation across various clinical specialties.
Critical & ICU Care
Comprehensive, culture-free identification within 24 hours when every single hour counts.
Elusive Infections
Uncovers rare or fastidious organisms which could be missed by conventional technology.
Polymicrobial Infections
Reliably detects polymicrobial & co-infections from a single sample.
Antimicrobial Stewardship
Pinpoints critical antimicrobial resistance genes to guide precise therapy.
From routine diagnostic challenges to the most elusive clinical enigmas, infexn®–NGS uncovers the complete microbial landscape so no infection is overlooked.
All-In-One Genomic Diagnostic Solutions
Each test serves as a single, definitive framework designed to eliminate guesswork and reveal the complete pathogen landscape in a single run
Your Go-To-Test for Infection Detection
- Pan-bacteria, pan-fungi, key ARGs
- Major respiratory & neuropathic viruses
- Culture-free test
- Results within 24 hours
For Tropical Fevers and Secondary Bloodstream Infections
- Dengue, malaria, typhoid & many more
- Detects co-infections and polymicrobial infections
- Direct-from-blood testing
- Most advanced molecular diagnosis
Complete Diagnostic Coverage for Upper Respiratory Illness
- Painless, ideal for pediatric use
- Key respiratory bacteria & viruses detected
- Sensitivity >95.45%, Specificity >99%
- Enables precise therapy guidance
Your Go-To-Test for Ocular Infection Detection
- Pan-bacteria, Pan-fungi
- Major ARGs
- HSV-1 and HSV-2 virus
- Reliably detects co-infections
Why infexn®-NGS Outperforms Conventional Tests
Moving from delayed, fragmented answers to absolute diagnostic clarity.
Traditional diagnostic frameworks like culture, microscopy, immunoassays, and PCR each solve a single, isolated piece of the infection puzzle. infexn®-NGS unifies the entire diagnostic pipeline, delivering comprehensive pathogen identification and antimicrobial resistance profiling end-to-end, from a single clinical sample.
Conventional Tests
Culture Testing
Long TAT; misses rare and difficult-to-culture organisms
Microscopy
Reduced sensitivity for low-abundance or mixed populations
Standard PCR
Requires pre-defined panels, often forcing empirical treatment
infexn®-NGS
Culture-free & Comprehensive
24-hour TAT; comprehensive detection of pathogens including rare and fastidious organisms
High-Sensitivity Detection
Reliably detects pathogens with high accuracy while also resolving polymicrobial or co-infections
Hypothesis-free
Detection of pan-bacteria, pan-fungi with major viruses & key ARGs enabling targeted therapy
What the infexn®-NGS Report Covers
Simple Integration. Rapid Insights.
A streamlined & optimized workflow designed to deliver comprehensive & actionable insights without adding operational complexity.
Seamlessly integrates into routine clinical workflows using standard clinical samples, including blood, tissue, swabs and more.
Bypasses the multi-day incubation bottleneck entirely using culture-free, high-throughput Next-Generation Sequencing (NGS) and proprietary bioinformatics.
Delivers a unified, comprehensive diagnostic overview mapping both pathogen detection and critical resistance markers within a 24-hour window.
Collaborate With Us
The leadership team
Prof. Kiran Kondabagil
Co-founder & Chief Scientific Mentor
HaystackAnalytics Pvt. Ltd.
Dr. Anirvan Chatterjee
Co-founder & CEO
HaystackAnalytics Pvt. Ltd.
Gaurav Srivastav
Co founder & COO
HaystackAnalytics Pvt. Ltd.
Scientific Advisory board
Dr. Aruna Poojary
Dr. Arunaloke Chakraborti
Dr. Pallab Ray
Dr. S K Todi
Testimonials
Dr. Nikhileshwar Prasad Verma
MBBS, MD, FICP
Internal Medicine Specialist
""infexn® is a time-saving procedure to identify and choose antibiotics properly.""
Dr. Ashit Naik
MBBS, MD
Pain Physician and Intensivist
Shri Medishine Hospital, Raipur
""infexn® has improved how I diagnose infections in patients. It has helped identify pathogens which were previously undiagnosed by conventional methods and has helped create personalized treatments and also in saving lives. infexn® is reliable and has an effective impact for patient care.""
Dr. Alfia Alim
MBBS, MD
Consultant Microbiologist & Head of Infection Control
Mediversal Multi-Super Specialty Hospital
""Reliable and timely diagnosis of pathogens in critically ill patients still poses major problems for intensive care medicine. Using Next Generation Sequencing (NGS) in combination with bioinformatic algorithms, this process is able to detect DNA fragments of pathogens in the patient's blood to identify the cause of the sepsis with highest specificity and sensitivity. NGS offered by HaystackAnalytics (infexn®) has a detection rate five to six times better than that of culture-based procedures with far less turnaround time.""
Dr. Nikhileshwar Prasad Verma
MBBS, MD, FICP
Internal Medicine Specialist
""infexn® is a time-saving procedure to identify and choose antibiotics properly.""
Dr. Ashit Naik
MBBS, MD
Pain Physician and Intensivist
Shri Medishine Hospital, Raipur
""infexn® has improved how I diagnose infections in patients. It has helped identify pathogens which were previously undiagnosed by conventional methods and has helped create personalized treatments and also in saving lives. infexn® is reliable and has an effective impact for patient care.""
Proudly Made in India
For the World
